Obscure Gastrointestinal Bleeding
10
2
2
4
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
10.0%
1 terminated out of 10 trials
80.0%
-6.5% vs benchmark
0%
0 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (10)
Endoscopic Evaluation for Iron Deficiency Anemia in Patients on Antithrombotic Therapy
Depth of Maximal Ileal Insertion During Retrograde Enteroscopy With TTS Balloon
Role of AI in CE for the Identification of SB Lesions in Patients With Small Intestinal Bleeding.
Assessing Depth of Small Bowel Insertion at Push Enteroscopy by Using Capsule Endoscopy
Preparation Regimens to Improve Capsule Endoscopy Visualization and Diagnostic Yield
Cap Assisted Balloon Enteroscopy Versus Conventional Balloon Enteroscopy In The Evaluation Of Obscure Gastrointestinal Bleeding: A Randomized Controlled Trial
Capsule Endoscopy in Obscure GI Bleeding
Long-term Effects of Thalidomide for Recurrent Gastrointestinal Bleeding Due to Vascular Malformation
Single Balloon Enterosocpy Obscure Gastrointestinal Bleeding Bleed
Diagnostic Evaluation of Obscure Gastrointestinal Bleeding